BlackRock Institutional Trust’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$58.6M Buy
2,090,392
+131,166
+7% +$3.68M 0.01% 1243
2016
Q3
$53.8M Buy
1,959,226
+9,566
+0.5% +$262K 0.01% 1257
2016
Q2
$42.5M Sell
1,949,660
-73,826
-4% -$1.61M 0.01% 1339
2016
Q1
$45.2M Sell
2,023,486
-20,674
-1% -$462K 0.01% 1288
2015
Q4
$56.5M Buy
2,044,160
+24,571
+1% +$679K 0.01% 1166
2015
Q3
$52.1M Sell
2,019,589
-18,116
-0.9% -$467K 0.01% 1206
2015
Q2
$50.5M Sell
2,037,705
-17,770
-0.9% -$441K 0.01% 1289
2015
Q1
$51.8M Buy
2,055,475
+39,024
+2% +$983K 0.01% 1299
2014
Q4
$47.3M Sell
2,016,451
-15,791
-0.8% -$370K 0.01% 1332
2014
Q3
$46.3M Buy
2,032,242
+6,112
+0.3% +$139K 0.01% 1300
2014
Q2
$49.5M Sell
2,026,130
-72,164
-3% -$1.76M 0.01% 1334
2014
Q1
$44.3M Buy
2,098,294
+1,696
+0.1% +$35.8K 0.01% 1364
2013
Q4
$49.9M Buy
2,096,598
+24,869
+1% +$592K 0.01% 1258
2013
Q3
$44.3M Sell
2,071,729
-50,719
-2% -$1.09M 0.01% 1278
2013
Q2
$42.3M Buy
+2,122,448
New +$42.3M 0.01% 1255

Other funds holding QGENF

BlackRock Institutional Trust's QGENF Position: Q4 2016 in Review

BlackRock Institutional Trust increased its QIAGEN NV (QGENF) stake by 6.7% in Q4 2016, buying an estimated $3.68M and bringing the position to 2,090,392 shares worth $58.6M. The position accounts for 0.01% of the portfolio, ranked #1243.

BlackRock Institutional Trust first reported a position in QGENF in Q2 2013 and has held it in 15 quarters since. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • BlackRock Institutional Trust held 2,090,392 shares of QIAGEN NV worth $58.6M as of Q4 2016.
  • BlackRock Institutional Trust bought 131,166 QIAGEN NV shares in Q4 2016, an estimated $3.68M.
  • QIAGEN NV made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1243 holding.
  • BlackRock Institutional Trust first reported a position in QIAGEN NV in Q2 2013 and has held it in 15 quarters since.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.